Cancer stem cells (CSCs) are the main culprits involved in therapy resistance and disease
recurrence in colorectal carcinoma (CRC). Results using cell culture, animal models and …

Colorectal cancer (CRC) is the third cause of cancer death worldwide. Although, in some
cases, treatment can increase patient survival and reduce cancer recurrence, in many …

Colorectal cancer (CRC) represents the third most commonly diagnosed cancer and the
second leading cause of cancer death worldwide. The modern concept of cancer biology …

Chemo-resistance is associated with poor prognosis in colorectal cancer (CRC), with the
absence of early biomarker. Exosomes are microvesicles released by body cells for …

The field of plasma medicine has seen substantial advances over the last decade, with
applications developed for bacterial sterilisation, wound healing and cancer treatment. Low …

Highlights•Exosomal miRNA plays a vital part in the initiation of dysregulated molecular
events.•Understanding exosomal miRNA in chemoresistance, immune-escape and …

Cancer handles an estimated 7.6 million deaths worldwide per annum. A recent theory
focuses on the role Cancer Stem Cells (CSCs) in driving tumorigenesis and disease …

Most cancers contain a subpopulation of highly tumorigenic cells, known as cancer stem
cells (CSCs) or tumor-initiating cells (TICs). Targeting TICs may be essential to achieve cure …

Colorectal cancer (CRC) is one of the most aggressive cancers worldwide. Several
anticancer agents are available to treat CRC, but eventually cancer relapse occurs. One …

Simple Summary Colorectal cancer stem cells (CR-CSCs) play a pivotal role in the therapy
resistance and relapse of CRC patients. Herein we demonstrate that new treatment …